These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2747070)

  • 21. [A study of interstitial pneumonia associated with collagen vascular disease--comparison with the data of idiopathic pulmonary fibrosis].
    Sato A; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():54-61. PubMed ID: 8007475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transthoracic lung biopsy in interstitial pulmonary diseases (author's transl)].
    Haenselt V; Liebetrau G
    Z Erkr Atmungsorgane; 1980; 155(3):305-13. PubMed ID: 7222792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update in diffuse parenchymal lung diseases 2005.
    Martinez FJ; Keane MP
    Am J Respir Crit Care Med; 2006 May; 173(10):1066-71. PubMed ID: 16679445
    [No Abstract]   [Full Text] [Related]  

  • 24. The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis.
    Manali ED; Stathopoulos GT; Kollintza A; Kalomenidis I; Emili JM; Sotiropoulou C; Daniil Z; Roussos C; Papiris SA
    Respir Med; 2008 Apr; 102(4):586-92. PubMed ID: 18162388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiotensin converting enzyme in lung diseases].
    Mayr K; Aspöck G; Mayer KH; Waibel K; Leitner L
    Wien Med Wochenschr; 1985 Mar; 135(5):109-13. PubMed ID: 2986367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.
    Mark EJ; Ruangchira-urai R
    Ann Diagn Pathol; 2008 Jun; 12(3):171-80. PubMed ID: 18486892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection.
    Bobbio A; Chetta A; Carbognani P; Internullo E; Verduri A; Sansebastiano G; Rusca M; Olivieri D
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):754-8. PubMed ID: 16140541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases.
    Katzenstein AL; Mukhopadhyay S; Myers JL
    Hum Pathol; 2008 Sep; 39(9):1275-94. PubMed ID: 18706349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the validity of spiroergometric parameters in the differentiation of circulatory and ventilatory physical limitation].
    Reuter M; Wassermann K
    Pneumologie; 1997 Apr; 51(4):353-8. PubMed ID: 9221381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results?
    Schildge J; Nagel C; Grun C
    Respiration; 2007; 74(5):553-7. PubMed ID: 17496412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physical training aspect of exercise testing: the evaluation of Master's double 2 step test, augmented Master's test and Cooper's submaximum single-level load exercise test (author's transl)].
    Fukuda I; Yoshida T; Yoritsune H; Kiso A; Kamide H
    Kokyu To Junkan; 1975 Nov; 23(11):985-92. PubMed ID: 1239805
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.
    Salisbury ML; Myers JL; Belloli EA; Kazerooni EA; Martinez FJ; Flaherty KR
    Am J Respir Crit Care Med; 2017 Sep; 196(6):690-699. PubMed ID: 28002680
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proceedings: Augmented Master's 2 step test].
    Fukuda I; Kamiide H; Fujiwara K; Yoshida T; Sano I
    Jpn Circ J; 1975 Jul; 39(7):864. PubMed ID: 1160038
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proceedings: Comparative study of Master's double 2 step test and aerobic programmed treadmill test; (1) electrocardiographical observation].
    Fukuda I; Kamiide H; Fujiwara K; Yoshida T; Nakanishi K
    Jpn Circ J; 1975 Jul; 39(7):864. PubMed ID: 1160039
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of Master's double 2 step test and "augmented" Master's 2 step test, with special reference to Cooper's submaximum single-level load treadmill test].
    Fukuda I; Kamide H; Yoshida T; Yoritsune G; Kiso T
    Nihon Rinsho; 1976 Jun; 34(6):1266-73. PubMed ID: 787585
    [No Abstract]   [Full Text] [Related]  

  • 36. International consensus statement on idiopathic pulmonary fibrosis.
    Costabel U; King TE
    Eur Respir J; 2001 Feb; 17(2):163-7. PubMed ID: 11334114
    [No Abstract]   [Full Text] [Related]  

  • 37. [Usefulness of an exercise pulmonary function test for differential diagnosis or treatment evaluation of restrictive pulmonary diseases].
    Homma Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Feb; 27(2):149-54. PubMed ID: 2747070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A prospective study of idiopathic interstitial pneumonia and collagen vascular disease preceded by interstitial pneumonia].
    Ohtsuka Y; Homma Y; Tanimura K; Ogasawara H; Kusaka H; Munakata M; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1209-13. PubMed ID: 2266627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrum of fibrosing diffuse parenchymal lung disease.
    Morgenthau AS; Padilla ML
    Mt Sinai J Med; 2009 Feb; 76(1):2-23. PubMed ID: 19170214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pulmonary blood volume in patients with interstitial pneumopathy and pulmonary heart disease. Its study at rest and during exercise].
    Verdejo J; Lupi-Herrera E; Sandoval J; Seoane M; Gómez A; Barrios R
    Arch Inst Cardiol Mex; 1988; 58(4):273-80. PubMed ID: 3190362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.